Biological Discovery through Chemical Innovation: Anti-Cancer Agents: New Opportunities for Cross Collaboration


Sumin Kang, PhD
Assoc Professor, Hematology & Medical Oncology
School of Medicine
Mark Goodman, PhD
Professor, Radiology & Imaging Sciences
School of Medicine
Hans Grossniklaus, MD, MBA
Professor, Ophthalmology
School of Medicine
Tobey MacDonald, MD
Professor, Neuro-Oncology
Renee Read, PhD
Asst Professor, Pharmacology
School of Medicine
Deborah DeRyckere, PhD
Asst Professor, Pediatrics
School of Medicine
Hui Mao, PhD
Professor, Radiology & Imaging Sciences
School of Medicine
Douglas Graham, MD, PhD
Professor, Leukemia Lymphoma

The Biological Discovery through Chemical Innovation (BDCI) initiative is holding a series of videoconference focused meetings this summer on topics that bridge biological, biomedical and chemical research. The intent of these meetings is to build connections and new collaborations across the campus.

The next meeting will be on “Anti-Cancer Agents: New Opportunities for Cross Collaboration”, and is scheduled for this Friday, June 26th at 12 pm and will last up to 1 hr.  The zoom link for the meeting is the following:

Join Zoom Meeting:

Meeting ID: 993 5418 4877

The meeting will be introduced by short presentations from Hui Mao, PhD (Radiology and Imaging Sciences) and Doug Graham, MD/PhD (Pediatrics).

This will be followed by a few flash talks that should discuss possible ways to expand the programs through collaborations.

Zoom Webinar
Atlanta, Georgia 30322
Tiffany Bell-Horwath, PhD